TL
Tirschwell & Loewy Portfolio holdings
AUM
$731M
This Quarter Return
+1.45%
1 Year Return
+15.45%
3 Year Return
+77.97%
5 Year Return
+97.59%
10 Year Return
–
AUM
$559M
AUM Growth
+$559M
(-7.1%)
Cap. Flow
-$45.7M
Cap. Flow
% of AUM
-8.19%
Top 10 Holdings %
Top 10 Hldgs %
40.06%
Holding
82
New
3
Increased
3
Reduced
62
Closed
2
Top Buys
| 1 |
Starbucks
SBUX
|
$3.55M |
| 2 |
Novo Nordisk
NVO
|
$338K |
| 3 |
Procter & Gamble
PG
|
$298K |
| 4 |
iShares S&P 500 Value ETF
IVE
|
$221K |
| 5 |
Norfolk Southern
NSC
|
$216K |
Top Sells
| 1 |
CPHD
Cepheid Inc
CPHD
|
$12.1M |
| 2 |
Williams-Sonoma
WSM
|
$3.66M |
| 3 |
Wells Fargo
WFC
|
$3.56M |
| 4 |
Cognex
CGNX
|
$3.05M |
| 5 |
W.W. Grainger
GWW
|
$1.63M |
Sector Composition
| 1 | Healthcare | 40.41% |
| 2 | Industrials | 12.47% |
| 3 | Technology | 12.19% |
| 4 | Consumer Staples | 7.57% |
| 5 | Financials | 5.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Cognex
CGNX
$7.38B
| $28.4M | 5.08% |
446,060
-47,895
| -10% | -$3.05M |
|
|
TIF
2
DELISTED
Tiffany & Co.
TIF
| $27.6M | 4.94% |
356,596
-14,350
| -4% | -$1.11M |
|
3
Analog Devices
ADI
$124B
| $23.2M | 4.16% |
319,951
-13,200
| -4% | -$959K |
|
4
Johnson & Johnson
JNJ
$427B
| $23.2M | 4.16% |
201,666
-5,240
| -3% | -$604K |
|
5
Neogen
NEOG
$1.25B
| $22.7M | 4.07% |
344,289
-19,635
| -5% | -$1.3M |
|
6
Biogen
BIIB
$19.4B
| $21.9M | 3.92% |
77,255
-4,655
| -6% | -$1.32M |
|
7
Brown-Forman Class B
BF.B
$14.2B
| $19.8M | 3.54% |
439,943
-18,804
| -4% | -$845K |
|
8
Idexx Laboratories
IDXX
$51.8B
| $19.5M | 3.48% |
165,940
-6,695
| -4% | -$785K |
|
|
RTN
9
DELISTED
Raytheon Company
RTN
| $18.9M | 3.38% |
132,897
-4,685
| -3% | -$665K |
|
10
Honeywell
HON
$139B
| $18.6M | 3.33% |
160,522
-3,320
| -2% | -$385K |
|
11
Danaher
DHR
$147B
| $18.5M | 3.3% |
237,116
-11,425
| -5% | -$889K |
|
12
DexCom
DXCM
$29.5B
| $15.7M | 2.8% |
262,270
-9,250
| -3% | -$552K |
|
13
Schlumberger
SLB
$55B
| $15.2M | 2.72% |
181,032
-11,225
| -6% | -$942K |
|
14
Mastercard
MA
$538B
| $15.1M | 2.7% |
146,155
-8,770
| -6% | -$906K |
|
15
Henry Schein
HSIC
$8.44B
| $14.8M | 2.65% |
97,544
-3,890
| -4% | -$590K |
|
|
16
Novo Nordisk
NVO
$251B
| $14.4M | 2.57% |
400,395
+9,425
| +2% | +$338K |
|
|
17
W.W. Grainger
GWW
$48.5B
| $12.9M | 2.31% |
55,577
-7,015
| -11% | -$1.63M |
|
18
Amgen
AMGN
$155B
| $12.1M | 2.16% |
82,432
-2,785
| -3% | -$407K |
|
19
Insulet
PODD
$23.9B
| $11.3M | 2.03% |
300,725
-15,500
| -5% | -$584K |
|
20
Inogen
INGN
$216M
| $11.1M | 1.99% |
165,200
-8,950
| -5% | -$601K |
|
21
Ross Stores
ROST
$48.1B
| $11M | 1.97% |
167,760
-3,230
| -2% | -$212K |
|
22
Dentsply Sirona
XRAY
$2.85B
| $9.84M | 1.76% |
170,475
-1,421
| -0.8% | -$82K |
|
23
GE Aerospace
GE
$292B
| $9.08M | 1.63% |
287,236
-7,900
| -3% | -$250K |
|
|
ABMD
24
DELISTED
Abiomed Inc
ABMD
| $9.06M | 1.62% |
80,415
-2,010
| -2% | -$226K |
|
25
Mettler-Toledo International
MTD
$26.8B
| $8.84M | 1.58% |
21,110
-1,425
| -6% | -$596K |
|